Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 9,466 | 16,139 | 9,551 | 11,514 | 9,622 |
| Gross Profit | 9,466 | 16,139 | 9,551 | 11,514 | 9,622 |
| Operating Expenses | 54,792 | 54,770 | 54,433 | 52,324 | 46,555 |
| Operating Income | -45,326 | -38,631 | -44,882 | -40,810 | -36,933 |
| Interest Expense | 55 | 58 | 36 | 41 | 41 |
| Other Income | 4,453 | 3,824 | 1,916 | 594 | 290 |
| Pre-tax Income | -40,928 | -34,865 | -43,002 | -40,257 | -36,684 |
| Net Income Continuous | -40,928 | -34,865 | -43,002 | -40,257 | -36,684 |
| Net Income | $-40,928 | $-34,865 | $-43,002 | $-40,257 | $-36,684 |
| EPS Basic Total Ops | -0.70 | -0.59 | -0.79 | -0.78 | -0.71 |
| EPS Basic Continuous Ops | -0.70 | -0.59 | -0.79 | -0.78 | -0.71 |
| EPS Diluted Total Ops | -0.70 | -0.59 | -0.79 | -0.78 | -0.71 |
| EPS Diluted Continuous Ops | -0.70 | -0.59 | -0.79 | -0.78 | -0.71 |
| EBITDA(a) | $-45,773 | $-38,718 | $-44,173 | $-39,428 | $-35,071 |